Cargando…
Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf
Acinetobacter baumannii is an important pathogen in hospital acquired infections. Although tigecycline currently remains a potent antibiotic for treating infections caused by multidrug resistant A. baumannii (MDRAB) strains, reports of tigecycline resistant isolates have substantially increased. The...
Autores principales: | Hua, Xiaoting, He, Jintao, Wang, Jingfen, Zhang, Linghong, Zhang, Linyue, Xu, Qingye, Shi, Keren, Leptihn, Sebastian, Shi, Yue, Fu, Xiaoting, Zhu, Pengfei, Higgins, Paul G., Yu, Yunsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274536/ https://www.ncbi.nlm.nih.gov/pubmed/34170209 http://dx.doi.org/10.1080/22221751.2021.1948804 |
Ejemplares similares
-
Alteration of adeS Contributes to Tigecycline Resistance and Collateral Sensitivity to Sulbactam in Acinetobacter baumannii
por: Yang, Yunxing, et al.
Publicado: (2023) -
Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023) -
Population Biology and Epidemiological Studies of Acinetobacter baumannii in the Era of Whole Genome Sequencing: Is the Oxford Scheme Still Appropriate?
por: Hua, Xiaoting, et al.
Publicado: (2020) -
Co‐evolutionary adaptations of Acinetobacter baumannii and a clinical carbapenemase‐encoding plasmid during carbapenem exposure
por: Zhang, Linyue, et al.
Publicado: (2022) -
Capsule Thickness, Not Biofilm Formation, Gives Rise to Mucoid Acinetobacter baumannii Phenotypes That are More Prevalent in Long-Term Infections: A Study of Clinical Isolates from a Hospital in China
por: Hu, Lihua, et al.
Publicado: (2020)